Search

Your search keyword '"Nayir, Ahmet"' showing total 2 results
Start Over Author "Nayir, Ahmet" Topic covid-19
2 results on '"Nayir, Ahmet"'

1. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.

Author

Gulmez R, Ozbey D, Agbas A, Aksu B, Yildiz N, Uckardes D, Saygili S, Yilmaz EK, Yildirim ZY, Tasdemir M, Kiykim A, Cokugras H, Canpolat N, Nayir A, Kocazeybek B, and Caliskan S

Subjects
Adult, Humans, Child, Male, COVID-19 Vaccines, BNT162 Vaccine, Case-Control Studies, Prospective Studies, Retrospective Studies, Renal Dialysis, SARS-CoV-2, Transplant Recipients, Antibodies, Viral, Immunity, Cellular, RNA, Messenger, Vaccination, Kidney Transplantation adverse effects, COVID-19 epidemiology, COVID-19 prevention & control
Abstract

Background: Compared with the general population, the immune response to COVID-19 mRNA vaccines is lower in adult kidney transplant recipients (KTRs). However, data is limited for pediatric KTRs. In this study, we aimed to assess humoral and cellular immune responses to the COVID-19 mRNA vaccine in pediatric KTRs., Methods: This multicenter, prospective, case-control study included 63 KTRs (37 male, aged 12-21 years), 19 dialysis patients, and 19 controls. Humoral (anti-SARS-CoV2 IgG, neutralizing Ab (nAb)) and cellular (interferon-gamma release assay (IGRA)) immune responses were assessed at least one month after two doses of BNT162b2 mRNA vaccine., Results: Among COVID-19 naïve KTRs (n = 46), 76.1% tested positive for anti-SARS-CoV-2 IgG, 54.3% for nAb, and 63% for IGRA. Serum levels of anti-SARS-CoV-2 IgG and nAb activity were significantly lower in KTRs compared to dialysis and control groups (p < 0.05 for all). Seropositivity in KTRs was independently associated with shorter transplant duration (p = 0.005), and higher eGFR (p = 0.007). IGRA titer was significantly lower than dialysis patients (p = 0.009). Twenty (43.4%) KTRs were positive for all immune parameters. Only four of 11 seronegative KTRs were IGRA-positive. COVID-19 recovered KTRs had significantly higher anti-SARS-CoV-2 IgG and nAb activity levels than COVID-19 naïve KTRs (p = 0.018 and p = 0.007, respectively)., Conclusions: The humoral and cellular immune responses to SARS-CoV-2 mRNA BNT162b2 vaccine are lower in pediatric KTRs compared to dialysis patients. Further prospective studies are required to demonstrate the clinical efficacy of the mRNA vaccine in KTRs. This prospective study was registered in ClinicalTrials.gov (NCT05465863, registered retrospectively at 20.07.2022). A higher resolution version of the Graphical abstract is available as Supplementary information., (© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)

Published
2023
Full Text
View/download PDF

2. COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation

Author

Harika Alpay, Duygu Övünç Hacıhamdioğlu, Zeynep Yuruk Yildirim, Gul Ozcelik, Bağdagül Aksu, Rumeysa Yasemin Cicek, Hasan Dursun, Önder Yavaşcan, Ahmet Nayir, Nurdan Yildiz, Rüveyda Gülmez, Mehmet Taşdemir, Havva Evrengül, Sebahat Tulpar, Nur Canpolat, Nilüfer Göknar, Acibadem University Dspace, Taşdemir, Mehmet, Canpolat, Nur, Yıldırım, Zeynep Yürük, Yıldız, Nurdan, Göknar, Nilufer, Evrengül, Havva, Gülmez, Ruveyda, Aksu, Bağdagül, Dursun, Hasan, Özçelik, Gül, Yavaşcan, Önder, Çicek, Rumeysa Yasemin, Tulpar, Sebahat, HacIhamdioğlu, Duygu Övünç, Nayır, Ahmet, Alpay, Harika, Koç University Hospital, İstinye Üniversitesi, Hastane, Evrengul, Havva, Yildirim, Zeynep Yuruk, Yildiz, Nurdan, Tasdemir, Mehmet, Goknar, Nilufer, Gulmez, Ruveyda, Aksu, Bagdagul, Ozcelik, Gul, Yavascan, Onder, Cicek, Rumeysa Yasemin, Hacihamdioglu, Duygu Ovunc, and Nayir, Ahmet

Subjects
Adult, medicine.medical_specialty, medicine.medical_treatment, HEMODIALYSIS-PATIENTS, Outcomes, Asymptomatic, Pediatrics, DISEASE, RRT, Kidney transplantation, Renal Dialysis, Internal medicine, medicine, Humans, Hemodialysis-Patients, Disease, Renal replacement therapy, Mortality, Child, Children, Dialysis, Mechanical ventilation, Pediatric, OUTCOMES, SARS-CoV-2, business.industry, MORTALITY, Incidence (epidemiology), COVID-19, medicine.disease, RECIPIENTS, Nephrology, Pediatrics, Perinatology and Child Health, Cohort, Kidney Failure, Chronic, Original Article, Recipients, Hemodialysis, medicine.symptom, business, Renal Replacement Therapy
Abstract

The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the number of prevalent RRT patients under the age of 20. A total of 46 confirmed cases of COVID-19 were reported from 12 centers, of which 17 were dialysis patients, and 29 were KTx recipients. Thus, the incidence rate of COVID-19 was 9.3% among dialysis patients and 9.2% among KTx recipients over a 9-month period in Istanbul. Twelve KTx recipients and three dialysis patients were asymptomatic (p = 0.12). Most of the symptomatic patients in both the dialysis and KTx groups had a mild respiratory illness. Only two patients, one in each group, experienced a severe disease course, and only one hemodialysis patient had a critical illness that required mechanical ventilation. In the entire cohort, one hemodialysis patient with multiple comorbidities died. Conclusion: while most cases are asymptomatic or have a mild disease course, pediatric patients undergoing dialysis and a kidney transplant are at increased risk for COVID-19. What is known: in adult population, both dialysis patients and kidney transplant recipients are at increased risk for severe illness of COVID-19 and have higher mortality rate. Children with kidney transplantation are not at increased risk for COVID-19 and most have mild disease course. Data on children on dialysis are scarce. What is new: pediatric patients undergoing dialysis and kidney transplantation have an increased risk for COVID-19. Most patients undergoing renal replacement therapy either on dialysis or transplanted develop asymptomatic or mild COVID-19 disease with a favorable outcome., NA

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results